Dr. Beate Aurich is a pharmacovigilance/ drug safety physician, general paediatrician (MRCPCH London) and a methodological expert for paediatric pharmacovigilance in the 'conecting4children' (c4c) network. She has twenty years of pharmacovigilance and drug safety experience in pharmaceutical industry and academia. She is a member of ISOP, ISPE and ESDPPP and fellow of the governance, ethics, evidence, policy, practice (GE2P2) Global Foundation. Currently she is the head of Drug Safety Consulting S.A.S.U., an independent pharmacovigilance and drug safety consultancy for academic and industry sponsored paediatric and adult clinical research.

Maria is a Clinical Pharmacology Director, with more than 20 years’ experience developing new drugs in therapy areas including Infection, Respiratory and Inflammation and Oncology, whilst at AstraZeneca. Maria has been fortunate to provide Clinical Pharmacology leadership for 3 medicines which have reached the market doing her career. Recently, developing medicines for paediatric patients has provided exciting challenges, such as using PK extrapolation to bridge efficacy data from older to younger patients and predicting the dose for very young children using modelling and simulation approaches. Maria received her PhD. from The School of Pharmacy, University of Manchester and lives in the North-West of England.